Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Completed

Phase N/A Results N/A

Main Contacts

Name Phone E-mail
Bayer Study Director Study Director

Other Locations

Name City State Country Status
Name Unavailable Many Locations Germany Unknown_status_icon